Neogen (NEOG) Non-Current Assets (2011 - 2026)
Neogen's (NEOG) quarterly Non-Current Assets came in at $2.8 billion in Q1 2026, up 1434.37% year-on-year from $180.5 million in Q1 2025, and down 0.59% quarter-over-quarter from $2.8 billion in Q4 2025.
Neogen (NEOG) Non-Current Assets (2011 - 2026) Analysis & Trends
Neogen's Non-Current Assets history runs 16 years deep, the most recent figure standing at $2.8 billion for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 1434.37% year-over-year to $2.8 billion in Q1 2026; TTM through Feb 2026 was $11.3 billion, a 64.9% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, down 27.6% from the prior year.
- Non-Current Assets eased to $2.8 billion in Q1 2026 per NEOG's latest filing, from $2.8 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $4.0 billion in Q1 2024 and bottomed at -$430.2 million in Q4 2024.
- The 5-year median for Non-Current Assets is $2.9 billion (2025), against an average of $2.5 billion.
- Across the five-year window, Non-Current Assets tumbled 110.81% in 2024 and jumped 1434.37% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $3.9 billion in 2022, then advanced by 1.48% to $4.0 billion in 2023, then tumbled by 110.81% to -$430.2 million in 2024, then jumped by 747.44% to $2.8 billion in 2025, then retreated by 0.59% to $2.8 billion in 2026.
- Per Business Quant, the three latest NEOG Non-Current Assets figures stand at $2.8 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 2.30 Bn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 26.70 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 20.47 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn | 2.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.77 Bn |
| Nov 30, 2025 | 2.79 Bn |
| Aug 31, 2025 | 2.85 Bn |
| May 31, 2025 | 2.87 Bn |
| Feb 28, 2025 | -207.51 Mn |
| Nov 30, 2024 | -430.22 Mn |
| Aug 31, 2024 | 3.52 Bn |
| May 31, 2024 | 3.96 Bn |
| Feb 29, 2024 | 3.98 Bn |
| Nov 30, 2023 | 3.98 Bn |
| Aug 31, 2023 | 3.98 Bn |
| May 31, 2023 | 3.97 Bn |
| Feb 28, 2023 | 3.95 Bn |
| Nov 30, 2022 | 3.92 Bn |
| Aug 31, 2022 | 369.50 Mn |
| May 31, 2022 | 366.13 Mn |
| Feb 28, 2022 | 371.57 Mn |
| Nov 30, 2021 | 356.73 Mn |
| Aug 31, 2021 | 322.98 Mn |
| May 31, 2021 | 328.74 Mn |